EdiGene Inc.

Quick facts

Phase 1 pipeline

• ATHENA CAR-T · Oncology
  CAR-T cell therapy targeting CD19

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• EdiGene Inc. portfolio CI brief
• EdiGene Inc. pipeline updates RSS